Tonix Pharmaceuticals Holding Profit Margin

The latest profit margin for TNXP is -387.45% as of June 2026. That compares with -224.88% in the prior-year period — down 72.3% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Tonix Pharmaceuticals Holding's historical trend and sector peers before judging valuation or financial health.

Over the past year, TNXP's profit margin moved from -224.88% to -387.45% — a 72.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Tonix Pharmaceuticals Holding's valuation or profitability profile.

Against Healthcare companies, TNXP currently prints -387.45% for profit margin, while the sector average sits near 13.89%. That is roughly 2889.4% below the sector mean. Large gaps often invite a closer look at Tonix Pharmaceuticals Holding's growth, margins, and balance sheet.

Profit Margin shows how effectively Tonix Pharmaceuticals Holding converts resources into returns. At -387.45%, TNXP may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -224.88% in the prior-year period — down 72.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting TNXP's profit margin (-387.45%), review year-over-year change from -224.88%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.